Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is -7.15% lower on its value in year-to-date trading and has touched a low of $0.26 and a high of $4.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNXP stock was last observed hovering at around $0.37 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.37, the stock is 8.43% and 3.27% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.33 million and changing 1.68% at the moment leaves the stock -58.10% off its SMA200. TNXP registered -91.33% loss for a year compared to 6-month loss of -59.74%. The firm has a 50-day simple moving average (SMA 50) of $4.05 and a 200-day simple moving average (SMA200) of -$0.13.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 17.30% gain in the last 1 month and extending the period to 3 months gives it a -23.48%, and is 6.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.59% over the week and 8.20% over the month.
Tonix Pharmaceuticals Holding Corp (TNXP) has around 117 employees, a market worth around $30.24M and $3.99M in sales. Profit margin for the company is -3094.01%. Distance from 52-week low is 43.92% and -92.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-101.54%).
Tonix Pharmaceuticals Holding Corp quarterly earnings per share for the current quarter are estimated at -$1.55 with sales reaching $5.75M over the same period.The EPS is expected to grow by 63.79% this year
48 institutions hold shares in Tonix Pharmaceuticals Holding Corp (TNXP), with institutional investors hold 28.61% of the company’s shares. The shares outstanding are 80.82M, and float is at 80.81M with Short Float at 0.74%. Institutions hold 28.61% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 0.4 million shares valued at $0.63 million. The investor’s holdings represent 2.24% of the TNXP Shares outstanding. As of Jun 29, 2023, the second largest holder is Renaissance Technologies, LLC with 0.21 million shares valued at $0.33 million to account for 1.19% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 85365.0 shares representing 0.48% and valued at over $0.13 million, while Acadian Asset Management. LLC holds 0.39% of the shares totaling 68743.0 with a market value of $0.11 million.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Activity
A total of 0 insider transactions have happened at Tonix Pharmaceuticals Holding Corp (TNXP) in the last six months, with sales accounting for 0 and purchases happening 0 times.
